Cancer Chemotherapy and Pharmacology, 0344-5704

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study

    Pavel, M., Borson-Chazot, F., Cailleux, A., Hörsch, D., Lahner, H., Pivonello, R., Tauchmanova, L., Darstein, C., Olsson, H., Tiberg, F. & Ferone, D., 2019, I : Cancer Chemotherapy and Pharmacology. 83, 2, s. 375-385

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2015
  4. Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity

    Levinsen, M., Rosthoj, S., Nygaard, U., Heldrup, J., Harila-Saari, A., Jonsson, O. G., Bechensteen, A. G., Abrahamsson, J., Lausen, B., Frandsen, T. L., Weinshilboum, R. M. & Schmiegelow, K., 2015, I : Cancer Chemotherapy and Pharmacology. 75, 1, s. 59-66

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2014
  6. A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function

    Slingerland, M., Hess, D., Clive, S., Sharma, S., Sandstrom, P., Niklas Loman, Porro, M. G., Mu, S., Waldron, E., Valera, S. & Gelderblom, H., 2014, I : Cancer Chemotherapy and Pharmacology. 74, 5, s. 1089-1098

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2012
  8. Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination

    Tavecchio, M., Munck, J. M., Cano, C., Newell, D. R. & Curtin, N. J., 2012 jan, I : Cancer Chemotherapy and Pharmacology. 69, 1, s. 155-64

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2008
  10. The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia

    Mollgard, L., Deneberg, S., Nahi, H., Bengtzen, S., Jonsson-Videsater, K., Thoas Fioretos, Anna Andersson, Paul, C. & Lehmann, S., 2008, I : Cancer Chemotherapy and Pharmacology. 62, 3, s. 439-448

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2006
  12. Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

    Feliu, J., Martín, G., Castro, J., A. Sundlov, Rodriguez-Jaráiz, A., Casado, E., Lomas, M., Madroñal, C., Galán, A., Belda, C. & Gonzalez-Barón, M., 2006, I : Cancer Chemotherapy and Pharmacology. 58, 4, s. 527-531 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2003
  14. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).

    Skärby, T., Jönsson, P., Lars Hjorth, Behrentz, M., Björk, O., Forestier, E., Jarfelt, M., Lönnerholm, G. & Höglund, P., 2003, I : Cancer Chemotherapy and Pharmacology. 51, 4, s. 311-320

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift